<bill session="116" type="h" number="2296" updated="2022-11-01T19:47:14Z">
  <state datetime="2019-07-17">REPORTED</state>
  <status>
    <unknown datetime="2019-07-17"/>
  </status>
  <introduced datetime="2019-04-12"/>
  <titles>
    <title type="display">More Efficient Tools to Realize Information for Consumers Act</title>
    <title type="official" as="introduced">To require reporting regarding certain drug price increases, and for other purposes.</title>
    <title type="short" as="reported to house">More Efficient Tools to Realize Information for Consumers Act</title>
    <title type="short" as="introduced">Fair Accountability and Innovative Research Drug Pricing Act of 2019</title>
    <title type="short" as="introduced">FAIR Drug Pricing Act of 2019</title>
  </titles>
  <sponsor bioguide_id="S001145"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2019-09-19"/>
    <cosponsor bioguide_id="D000399" joined="2019-07-12"/>
    <cosponsor bioguide_id="G000568" joined="2019-07-18"/>
    <cosponsor bioguide_id="P000607" joined="2019-09-19"/>
    <cosponsor bioguide_id="R000607" joined="2019-04-12"/>
    <cosponsor bioguide_id="S001168" joined="2019-07-12"/>
    <cosponsor bioguide_id="S001201" joined="2019-08-20"/>
    <cosponsor bioguide_id="U000040" joined="2019-07-12"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-12">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-04-12" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-04-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-05-21">
      <text>Subcommittee Hearings Held.</text>
    </action>
    <action datetime="2019-07-11">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2019-07-11">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
    </action>
    <action datetime="2019-07-17">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2019-07-17" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2019-09-24">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.</text>
    </action>
    <calendar datetime="2019-09-24" calendar="Union" number="170">
      <text>Placed on the Union Calendar, Calendar No. 170.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Hearings, Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="3" relation="unknown"/>
    <bill session="116" type="h" number="19" relation="unknown"/>
    <bill session="116" type="h" number="2087" relation="unknown"/>
    <bill session="116" type="h" number="2115" relation="unknown"/>
    <bill session="116" type="h" number="2376" relation="unknown"/>
    <bill session="116" type="h" number="2452" relation="unknown"/>
    <bill session="116" type="h" number="3408" relation="unknown"/>
    <bill session="116" type="h" number="3415" relation="unknown"/>
    <bill session="116" type="s" number="1227" relation="unknown"/>
    <bill session="116" type="s" number="1391" relation="unknown"/>
    <bill session="116" type="s" number="1895" relation="unknown"/>
    <bill session="116" type="s" number="2051" relation="unknown"/>
    <bill session="116" type="h" number="7898" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Corporate finance and management"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Inflation and prices"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-10T20:18:28Z" status="Reported to House">More Efficient Tools to Realize Information for Consumers Act or the METRIC Act This bill requires prescription drug manufacturers to report, and the Department of Health and Human Services (HHS) to publish, specified information related to prescription drug pricing and the pharmaceutical supply chain. Specifically, HHS must publish reports submitted by drug manufacturers that include the percentage of any wholesale drug price increase that is greater than 10% in one calendar year (or 25% over three consecutive years), an explanation for the price increase, and other data. HHS must enter agreements with other agencies, research organizations, and public and private health insurers to share data submitted to HHS by drug manufacturers about the identity and quantity of drug sample requests by health practitioners. HHS also must publish online aggregate data reported by pharmacy benefits managers (PBMs), including the percentage of prescriptions provided by mail-order, rate that generic versions of drugs are dispensed, and aggregate discounts, rebates, or price concessions negotiated. The bill requires the Federal Trade Commission to report about potentially anticompetitive practices by PBMs such as steering patients to certain pharmacies or designing price formulas that increase the market share of higher priced drugs, among other information. The report also must include recommendations to increase transparency and deter anticompetitive behavior. The bill further requires Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that provides prescribers with patient-specific formulary and benefit information. Additionally, the bill expands certain price reporting requirements for prescription drug payments under Medicare.</summary>
  <committee-reports>
    <report>H. Rept. 116-215</report>
  </committee-reports>
</bill>
